Neumora Therapeutics, Inc. (NMRA)
NASDAQ:NMRA
US Market
Holding NMRA?
Track your performance easily

Neumora Therapeutics, Inc. (NMRA) Financial Statements

135 Followers

Neumora Therapeutics, Inc. Financial Overview

Neumora Therapeutics, Inc.'s market cap is currently ―. The company's EPS TTM is $-1.738; its P/E ratio is -6.85; Neumora Therapeutics, Inc. is scheduled to report earnings on November 12, 2024, and the estimated EPS forecast is $-0.39. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Sep 23Jun 23Dec 22
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT£ -63.82M£ -60.07M---
EBITDA£ -63.66M£ -59.92M---
Net Income Common Stockholders£ -58.70M£ -53.72M£ -53.03M--
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments£ 371.64M£ 422.71M£ 509.56M£ 324.20M£ 371.88M
Total Assets£ 404.47M£ 450.21M£ 544.75M£ 359.95M£ 426.23M
Total Debt£ 3.61M£ 4.43M£ 6.14M£ 6.82M£ 8.44M
Net Debt£ -368.03M£ -418.29M£ -503.42M£ -317.38M£ -363.44M
Total Liabilities£ 23.21M£ 25.67M£ 32.06M£ 29.81M£ 29.40M
Stockholders Equity£ 381.26M£ 424.54M£ 512.69M£ 330.15M£ 396.84M
Cash Flow-
Free Cash Flow£ -56.16M£ -42.95M£ -47.81M--
Operating Cash Flow£ -56.16M£ -42.95M£ -47.77M--
Investing Cash Flow£ 21.25M£ -150.00M£ 23.82M--
Financing Cash Flow£ 2.65M£ 1.84M£ 232.02M--
Currency in GBP

Neumora Therapeutics, Inc. Earnings and Revenue History

Neumora Therapeutics, Inc. Debt to Assets

Neumora Therapeutics, Inc. Cash Flow

Neumora Therapeutics, Inc. Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis